exploring frontiers of bioscience

The Paul G. Allen Frontiers Group explores the landscape of science to identify and invest in pioneers with ideas that will create new knowledge and make the world better. Through continuous dialogue with scientists and visionaries around the world, the Frontiers Group will uncover novel ideas in bioscience with the potential to transform fields.  The Frontiers Group will help to create new ways of doing science, new ways of solving problems, and foster a creative community that imagines and creates the future.

Landscape perspective

We engage with scientists and visionaries around the world to uncover and make visible emerging frontiers and new directions in science. We convene creative partners in novel ways to imagine possible futures.

Funding new ideas

We invest in investigators and centers for frontier explorations that lead to new fundamental insights and produce important solutions with big impact.

Creative synthesis

We link ideas across the landscape of quantitative fields now addressing bioscience research and seek out creative approaches that span disciplines.

Current funding opportunities

Shedding light on the unknown role of the extracellular matrix in heart health and disease is the focus of an innovative collaboration between the American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease, and The Paul G. Allen Frontiers Group.

There will be two significant grants of $1.5 million each for pioneering researchers to make strides toward solving cardiovascular disease.

Learn more and apply here.


Allen Discovery Center researchers use bioelectric code to override genetic code

May 23, 2017

Researchers at the Allen Discovery Center at Tufts University have shown that permanent changes to flatworm body plans can be made not by manipulating the genome, but by resetting their bioelectric code.


News from The Paul G. Allen Frontiers Group: March 2017

March 30, 2017

Highlights include Exploring Frontiers: Connecting Neurodegeneration and Cancer, news on Allen Distinguished Investigators Jay Shendure and Svante Pääbo, and ADIs named in the first set of awardees from Chan Zuckerberg Biohub.